International Journal of Clinical Pharmacy

, Volume 37, Issue 1, pp 4–7 | Cite as

General practitioner views of an electronic high-risk medicine proforma to facilitate information transfer

  • Gordon F. RushworthEmail author
  • Lesley Diack
  • Ian G. Rudd
  • Derek Stewart
Short Research Report


Background The potential of warfarin related harm is increased if clinicians lack the full patient specific information to make informed decisions—an e-proforma has been developed to communicate this information on hospital discharge. Objective To determine the views of general practitioners (GPs) on a warfarin discharge e-proforma. Method A cross-sectional survey of all GPs (n = 272) within the Raigmore Hospital catchment area of NHS Highland, Scotland. Results The response rate was 39.3 % (107/272). 84 (78.5 %) noticed recent changes to information supplied on discharge for warfarin patients. 64 (59.8 %) respondents thought this would result in more informed prescribing with regards to dosing, while 65 (60.7 %) felt this would improve safety. Accurate completion, timely receipt of the e-proforma and a realistic date for subsequent INR tests were considered important by GPs. Conclusion This study suggests the use of an e-proforma to communicate information about a high-risk medication, warfarin, to GPs on discharge optimises safe, informed prescribing and monitoring in primary care. The development of a discharge e-proforma for other high-risk medication as a patient safety improvement measure should be explored.


High-risk medication Integrated care Patient safety Primary care Warfarin 



We acknowledge the involvement of Joanne Joyce and Robert Kelly in questionnaire distribution and data entry. We also thank all respondents for their time contributing to this study.


No funding was obtained to conduct this study.

Conflicts of interest

The authors declare that there are no conflicts of interest.


  1. 1.
    Rooney KD, Leitch J. Advancing patient safety—the Scottish patient safety programme. Anaesth News. 2009;260:20–1.Google Scholar
  2. 2.
    Department of Health, National Audit Office. A safer place for patients: learning to improve patient safety. London: National Audit Office; 2005. Accessed Sept/22 2014.
  3. 3.
    Rooney KD, Leitch J. Quality and safety in NHS Scotland. Br J Diabetes Vasc Dis. 2010;10:98–100.CrossRefGoogle Scholar
  4. 4.
    Royal College of General Practitioners Scotland, Royal Pharmaceutical Society Scotland. RCGP Scotland and RPS Scotland Joint Statement: Breaking down the barriers—how pharmacists and GPs can work together to improve patient care.–scotland-pdfs/rpsscotlandrcgpjointstatement.pdf. Accessed Feb/24, 2014.
  5. 5.
    Coleman EA, Berenson RA. Lost in transition: challenges and opportunities for improving the quality of transitional care. Ann Intern Med. 2004;141:533–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Rogers G, Alper E, Brunelle D, Federico F, Fenn CA, Leape LL, et al. Reconciling medications at admission: safe practice recommendations and implementation strategies. Jt Comm J Qual Patient Saf. 2006;32:37–50.PubMedGoogle Scholar
  7. 7.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:61–167.CrossRefGoogle Scholar
  8. 8.
    Moore C, Wisnivesky J, Williams S, McGinn T. Medical errors related to discontinuity of care from an inpatient to an outpatient setting. J Gen Int Med. 2003;18:646–51.CrossRefGoogle Scholar
  9. 9.
    Taylor C. Improving e-discharge letters for permanent pacemaker insertions at Wansbeck general Hospital. BMJ Qual Improv Rep. 2013;. doi: 10.1136/bmjquality.u201251.w772.Google Scholar
  10. 10.
    MacLure K, Stewart D, Strath A. A systematic review of medical and non-medical practitioners’ views of the impact of ehealth on shared care. Eur J Hosp Pharm. 2014;21:54–62.Google Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Gordon F. Rushworth
    • 1
    • 2
    • 3
    Email author
  • Lesley Diack
    • 3
  • Ian G. Rudd
    • 2
  • Derek Stewart
    • 3
  1. 1.Highland Clinical Research FacilityCentre for Health ScienceInvernessUK
  2. 2.NHS HighlandInvernessUK
  3. 3.School of Pharmacy and Life SciencesRobert Gordon UniversityAberdeenUK

Personalised recommendations